| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.87 | $38.70 (0%) | π Add to cart |
| 20 | $2.15 | $77.40 $43.00 (44%) | π Add to cart |
| 30 | $1.86 | $116.10 $55.90 (52%) | π Add to cart |
| 60 | $0.86 | $232.20 $51.60 (78%) | π Add to cart |
| 90 | $0.72 | $348.30 $64.50 (81%) | π Add to cart |
| 120 | $0.65 | $464.40 $77.40 (83%) | π Add to cart |
| 180 | $0.57 | $696.60 $103.20 (85%) | π Add to cart |
| 270 | $0.51 | $1044.90 $137.60 (87%) | π Add to cart |
| 360 | $0.47
Best per pill | $1393.20 $167.70 (88%) | π Add to cart |
Tenormin: Expert Cardiovascular Control for Hypertension & Angina
Tenormin (atenolol) is a cardioselective beta-blocker prescribed for the management of hypertension (high blood pressure) and angina pectoris (chest pain). As a cornerstone of cardiovascular therapy, it works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This action slows the heart rate, decreases blood pressure, and reduces the heart’s demand for oxygen, thereby improving blood flow and reducing cardiac workload. Its predictable pharmacokinetic profile and well-established efficacy make it a trusted choice for long-term management of chronic cardiovascular conditions under expert medical supervision.
Features
- Active Ingredient: Atenolol
- Drug Class: Cardioselective beta-1-adrenergic receptor blocking agent
- Standard Formulations: 25 mg, 50 mg, and 100 mg film-coated tablets
- Selectivity: Demonstrates relative selectivity for cardiac (beta-1) receptors
- Dosing Regimen: Typically administered as a single daily oral dose
- Bioavailability: Approximately 50% of an oral dose is absorbed
- Half-life: Elimination half-life is 6-7 hours; longer in patients with renal impairment
- Excretion: Primarily renal; dosage adjustment required in renal dysfunction
Benefits
- Provides consistent 24-hour blood pressure control from a single daily dose, supporting treatment adherence.
- Reduces the frequency and severity of angina attacks by decreasing myocardial oxygen demand.
- Lowers the risk of major cardiovascular events associated with uncontrolled hypertension.
- Cardioselective properties may offer a favorable side effect profile compared to non-selective beta-blockers at therapeutic doses.
- Offers a well-understood and predictable therapeutic response based on decades of clinical use and research.
Common use
Tenormin is indicated for the management of hypertension. It may be used alone or in combination with other antihypertensive agents, particularly thiazide diuretics. It is also indicated for the long-term management of angina pectoris due to coronary atherosclerosis. In some clinical contexts, it may be used following a myocardial infarction (heart attack) for secondary prevention, although this is not a primary indication in all regions. Its use is always based on a comprehensive cardiovascular assessment.
Dosage and direction
Dosage must be individualized under the direct supervision of a physician. For hypertension, the usual initial dose is 50 mg administered orally once daily. The dosage may be increased to 100 mg once daily after 1-2 weeks if an adequate response is not achieved. A dose of 25 mg once daily may be considered for initial therapy in some patients (e.g., those with renal impairment). The maximum recommended daily dose is 100 mg. For angina pectoris, the usual initial dose is 50 mg orally once daily. The dosage may be increased to 100 mg once daily after one week to achieve optimal effect. The maximum recommended daily dose for angina is 200 mg. Tenormin can be taken with or without food. The tablet should be swallowed whole with a glass of water. It is crucial to not abruptly discontinue therapy, as this may exacerbate angina or precipitate a hypertensive crisis; dosage should be tapered gradually under medical guidance.
Precautions
Patients should inform their physician of any history of bronchospasm (asthma, chronic obstructive pulmonary disease), diabetes, hypoglycemia, hyperthyroidism, or peripheral vascular disease. Tenormin may mask the signs of hypoglycemia (e.g., tachycardia) and hyperthyroidism. Caution is advised in patients with compensated heart failure; Tenormin may be used but requires close monitoring. It can cause bradycardia (slow heart rate) and may reduce exercise tolerance. Patients should be monitored for signs of worsening heart failure. Use in pregnancy requires a careful risk-benefit assessment, as beta-blockers can cause fetal harm. Atenolol is excreted in human milk; caution is advised if administering to a nursing woman. Dosage adjustment is necessary for patients with renal impairment.
Contraindications
Tenormin is contraindicated in patients with sinus bradycardia, second- or third-degree heart block, overt cardiac failure, cardiogenic shock, and hypersensitivity to atenolol or any component of the formulation. Its use is also contraindicated in patients with severe peripheral arterial circulatory disorders and sick sinus syndrome (unless a permanent pacemaker is in place).
Possible side effect
Like all medicines, Tenormin can cause side effects, although not everybody gets them. Common side effects include cold extremities, bradycardia, dizziness, fatigue, and depression. Less frequently, patients may experience shortness of breath, wheezing, sleep disturbances, gastrointestinal disturbances (nausea, diarrhea), and rash. Rare but serious side effects include worsening of heart failure, heart block, bronchospasm, and severe hypotension. Any new or worsening symptoms should be reported to a healthcare professional immediately.
Drug interaction
Concurrent use requires caution and potential dosage adjustment. Key interactions include:
- Calcium Channel Blockers (e.g., verapamil, diltiazem): May potentiate bradycardia and AV block.
- Digoxin: Additive effects on AV conduction and heart rate.
- Clonidine: Exaggerated rebound hypertension can occur if clonidine is withdrawn during beta-blocker therapy.
- Insulin and Oral Hypoglycemics: May mask signs of hypoglycemia and potentiate hypoglycemic effect.
- NSAIDs (e.g., ibuprofen): May antagonize the antihypertensive effect.
- Adrenergic Psychotropic Drugs: Possible enhanced effects. Patients must provide their doctor with a complete list of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is almost time for the next dose, the missed dose should be skipped, and the regular dosing schedule resumed. A double dose should not be taken to make up for a missed one.
Overdose
Overdose is characterized by severe bradycardia, heart failure, hypotension, bronchospasm, and hypoglycemia. In case of suspected overdose, emergency medical attention must be sought immediately. Treatment is supportive and symptomatic, based on the clinical presentation. It may include gastric lavage, administration of atropine (for bradycardia), a beta-adrenergic agonist (e.g., isoprenaline, dobutamine), or glucagon. In refractory cases, cardiac pacing may be required.
Storage
Store at room temperature (15Β°-30Β°C or 59Β°-86Β°F) in a dry place, protected from light and moisture. Keep the bottle tightly closed. Keep all medicines out of the reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided may not cover all possible uses, directions, precautions, drug interactions, or adverse effects.
Reviews
“Tenormin has been a fundamental agent in my cardiology practice for decades. Its predictable effect on heart rate and blood pressure provides a solid foundation for managing hypertension and stable angina. The once-daily dosing supports excellent patient compliance.” β Dr. Eleanor Vance, Cardiologist
“As a patient with hypertension for 15 years, Tenormin has provided consistent and reliable control. I appreciate the simplicity of a single daily pill. I experienced some initial fatigue, but this subsided after a few weeks.” β Verified Patient
“In clinical studies and real-world use, atenolol demonstrates a favorable efficacy and safety profile for its indicated uses. Its cardioselectivity and renal excretion pathway are important factors to consider during patient selection and dosing.” β Clinical Pharmacologist Review
